Parkinson disease in long term care facilities: a review of the literature

J Am Med Dir Assoc. 2014 Feb;15(2):90-4. doi: 10.1016/j.jamda.2013.10.007. Epub 2013 Dec 4.

Abstract

Parkinson disease (PD) is common in long term care (LTC) facilities. The number of institutionalized patients with PD will rise sharply in the coming decades because of 2 concurrent phenomena: aging of the population leads to an increased PD prevalence and improved quality of care has led to a prolonged survival in advanced disease stages. Only a few studies have investigated the prevalence and clinical characteristics of patients with PD in LTC facilities. Even fewer studies have addressed the treatment strategies used to support these institutionalized patients, who are mostly in advanced stages of the disease. The available evidence suggests that current management of patients with PD in LTC facilities is less than optimal. In the Netherlands, and we suspect in many other countries, there are no formal guidelines for treating patients with PD who have been admitted to a LTC facility. In this review, we describe the epidemiology, clinical characteristics, and clinical management of patients with PD in LTC settings. We also address potentially modifiable elements of care and provide several recommendations to improve the management of PD in these facilities. We conclude by suggesting a possible guide for future research in this area.

Keywords: Parkinson disease; diagnostic accuracy; long term care facilities; nursing homes; prevalence; review.

Publication types

  • Review

MeSH terms

  • Age Factors
  • Antiparkinson Agents / therapeutic use
  • Dementia / epidemiology
  • Depression / epidemiology
  • Disability Evaluation
  • Hallucinations / epidemiology
  • Humans
  • Long-Term Care
  • Motor Skills Disorders / etiology
  • Nursing Homes*
  • Parkinson Disease / diagnosis
  • Parkinson Disease / epidemiology*
  • Parkinson Disease / therapy*
  • Prevalence
  • Risk Factors
  • Specialization

Substances

  • Antiparkinson Agents